Substance Records

( (7) | 1 (12) | 2 (16) | 3 (18) | 4 (21) | 5 (7) | 6 (2) | 7 (2) | A (33) | B (23) | C (22) | D (31) | E (13) | F (14) | G (2) | H (6) | I (1) | J (3) | K (4) | L (5) | M (33) | N (26) | O (5) | P (31) | Q (1) | R (2) | S (3) | T (17) | U (2) | V (3) | X (1) | Z (4)
Title Drug Class Year(s) and type of review / ECDD meetings
AB-CHMINACA cannabinoid 39th ECDD (2017) - Critical review
AB-FUBINACA cannabinoid 42nd ECDD (2019) - Critical review
AB-PINACA cannabinoid 39th ECDD (2017) - Critical review
Acecarbromal sedative 24th ECDD (1988) - Critical review
Acetorphine opioid 15th ECDD (1966) - Critical review
Acetyl-alpha-methylfentanyl opioid 24th ECDD (1988) - Critical review
Acetyldihydrocodeine opioid 2nd ECDD (1950) - Critical review, 3rd ECDD (1952) - Critical review
Acetylfentanyl opioid 37th ECDD (2015) - Critical review
Acetylmethadol opioid 3rd ECDD (1952) - Critical review
Acryloylfentanyl opioid 39th ECDD (2017) - Critical review
ADB-BUTINACA cannabinoid 45th ECDD (2022) - Critical review
ADB-CHMINACA cannabinoid 41st ECDD (2018) - Critical review
ADB-FUBINACA cannabinoid 41st ECDD (2018) - Critical review
Adinazolam benzodiazepine 45th ECDD (2022) - Critical review
AH-7921 opioid 36th ECDD (2014) - Critical review
Allobarbital sedative 23rd ECDD (1987) - Critical review
Allylprodine opioid 10th ECDD (1960) - Critical review
Alpha-acetylmethadol opioid 4th ECDD (1954) - Critical review
Alpha-methadol opioid 4th ECDD (1954) - Critical review
Alpha-methylfentanyl opioid 24th ECDD (1988) - Critical review
Alpha-methylthiofentanyl opioid 26th ECDD (1989) - Critical review
Alpha-methyltryptamine (AMT) stimulant 36th ECDD (2014) - Critical review
Alpha-PHP stimulant 42nd ECDD (2019) - Critical review
Alpha-PiHP stimulant 45th ECDD (2022) - Critical review
Alpha-Pyrrolidinovalerophenone stimulant 37th ECDD (2015) - Critical review
Alphameprodine opioid 7th ECDD (1957) - Critical review
AM-2201 cannabinoid 36th ECDD (2014) - Critical review
Amfepramone stimulant 32nd ECDD (2001) – Pre-review, 33rd ECDD (2003) - Critical review
Amineptine stimulant 32nd ECDD (2001) – Pre-review, 33rd ECDD (2003) - Critical review
Aminorex stimulant 28th ECDD (1993) - Pre-review, 29th ECDD (1995) - Critical review
Amphetamine stimulant 17th ECDD (1970) - Critical review
APINACA cannabinoid 36th ECDD (2014) - Critical review, 42nd ECDD (2019) - Critical review
Aprobarbital sedative 23rd ECDD (1987) - Critical review